ELVN
Enliven Therapeutics Inc.
44.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.08 | 0.02 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| – | – | – | – | – | – | – | – | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -0.08 | -0.02 | – | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | 0.00 | 0.00 | – | – | |
| 0.82 | 1.01 | 1.19 | 1.38 | 1.40 | 1.83 | 2.20 | 2.04 | 1.62 | 2.27 | 1.67 | 1.04 | 1.07 | 1.21 | 1.19 | 1.25 | 0.64 | 0.37 | 0.48 | 0.44 | 0.47 | 0.39 | 0.44 | 0.42 | 0.50 | 0.41 | 0.29 | 0.37 | 0.33 | 0.44 | 1.35 | |
| 0.15 | 0.28 | 0.40 | 0.36 | 0.38 | 0.57 | 0.68 | 0.59 | 0.72 | 0.70 | 0.52 | 0.23 | 0.25 | 0.16 | 0.47 | 0.30 | 0.25 | 0.09 | 0.08 | 0.12 | 0.14 | 0.12 | 0.12 | 0.12 | 0.14 | 0.14 | 0.11 | 0.23 | 0.11 | 0.12 | 0.53 | |
| 0.97 | 1.29 | 1.59 | 1.73 | 1.77 | 2.40 | 2.88 | 2.63 | 2.33 | 2.97 | 2.19 | 1.28 | 1.32 | 1.37 | 1.66 | 1.55 | 0.89 | 0.49 | 0.59 | 0.55 | 0.62 | 0.51 | 0.56 | 0.54 | 0.63 | 0.55 | 0.40 | 0.60 | 0.44 | 0.56 | 1.88 | |
| -0.97 | -1.29 | -1.59 | -1.73 | -1.77 | -2.40 | -2.88 | -2.63 | -2.34 | -2.97 | -2.19 | -1.28 | -1.32 | -1.37 | -1.66 | -1.55 | -0.89 | -0.49 | -0.59 | -0.55 | -0.62 | -0.51 | -0.56 | -0.54 | -0.63 | -0.55 | -0.40 | -0.61 | -0.44 | -0.56 | -1.88 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.01 | 0.02 | 0.04 | – | 0.09 | – | – | 0.04 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.97 | -1.25 | -1.53 | -1.68 | -1.74 | -2.37 | -2.86 | -2.63 | -2.33 | -2.97 | -2.19 | -1.28 | -1.32 | -1.35 | -1.61 | -1.45 | -0.80 | -0.41 | -0.51 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.49 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 | |
| -0.01 | 0.03 | 0.06 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | 0.04 | 0.01 | -0.09 | 0.00 | -0.09 | 0.13 | 0.00 | 0.00 | – | -0.01 | – | – | – | – | – | – | – | |
| -0.97 | -1.25 | -1.53 | -1.68 | -1.74 | -2.37 | -2.86 | -2.63 | -2.33 | -2.97 | -2.19 | -1.28 | -1.32 | -1.35 | -1.61 | -1.45 | -0.80 | -0.41 | -0.51 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.49 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 | |
| -0.97 | -1.25 | -1.53 | -1.67 | -1.74 | -2.37 | -2.86 | -2.62 | -2.33 | -2.97 | -2.19 | -1.27 | -1.31 | -1.34 | -1.60 | -1.44 | -0.79 | -0.41 | -0.50 | -0.47 | -0.54 | -0.41 | -0.48 | -0.46 | -0.57 | -0.48 | -0.32 | -0.52 | -0.38 | -0.49 | -1.60 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.